Cargando…
Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837118/ https://www.ncbi.nlm.nih.gov/pubmed/29505609 http://dx.doi.org/10.1371/journal.pone.0193747 |
_version_ | 1783304059010154496 |
---|---|
author | Srihirun, Sirada Piknova, Barbora Sibmooh, Nathawut Schechter, Alan N. |
author_facet | Srihirun, Sirada Piknova, Barbora Sibmooh, Nathawut Schechter, Alan N. |
author_sort | Srihirun, Sirada |
collection | PubMed |
description | Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline P-VASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 μM) increased P-VASP(Ser239) in platelets about 31% at 10–20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20–40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions. |
format | Online Article Text |
id | pubmed-5837118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58371182018-03-19 Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes Srihirun, Sirada Piknova, Barbora Sibmooh, Nathawut Schechter, Alan N. PLoS One Research Article Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline P-VASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 μM) increased P-VASP(Ser239) in platelets about 31% at 10–20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20–40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions. Public Library of Science 2018-03-05 /pmc/articles/PMC5837118/ /pubmed/29505609 http://dx.doi.org/10.1371/journal.pone.0193747 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Srihirun, Sirada Piknova, Barbora Sibmooh, Nathawut Schechter, Alan N. Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title | Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title_full | Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title_fullStr | Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title_full_unstemmed | Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title_short | Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
title_sort | phosphorylated vasodilator-stimulated phosphoprotein (p-vasp(ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837118/ https://www.ncbi.nlm.nih.gov/pubmed/29505609 http://dx.doi.org/10.1371/journal.pone.0193747 |
work_keys_str_mv | AT srihirunsirada phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes AT piknovabarbora phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes AT sibmoohnathawut phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes AT schechteralann phosphorylatedvasodilatorstimulatedphosphoproteinpvaspser239inplateletsisincreasedbynitriteandpartiallydeoxygenatederythrocytes |